This article is a correction to:
Autoantibodies in Renal Diseases – Clinical Significance and Recent Developments in Serological Detection
Gianna Mastroianni-Kirsztajn
Nora Hornig
Wolfgang Schlumberger- 1Division of Nephrology, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil
- 2EUROIMMUN Medizinische Labordiagnostika AG, Institute for Experimental Immunology, Lübeck, Germany
A Corrigendum on
Autoantibodies in renal diseases – clinical significance and recent developments in serological detection
by Mastroianni-Kirsztajn, G., Hornig, N., and Schlumberger, W. (2015). Front. Immunol. 6:221. doi: 10.3389/fimmu.2015.00221
In the original article, there was a mistake in Figure 1 as published. The images of MPO and GBM microdots had been processed and display too high similarities.
FIGURE 1
Figure 1. MPO-ANCA fluorescence pattern on the EUROIMMUN EUROPLUS™ Granulocyte Mosaic (IgG). (A) Examplary microscope slide with 10 reaction fields, each containing 6 biochips forming a mosaic. (B) In the EUROPLUS™ Granulocyte Mosaic, each biochip represents a different substrate: ethanol-fixed granulocytes [granulocytes (EOH)], formalin-fixed granulocytes [granulocytes (HCHO)], HEp-2 cells in combination with ethanol-fixed granulocytes [HEp-2 cells + granulocytes (EOH)] as well as PR3, MPO, and GBM microdots. The exemplary images illustrate the reactivity of a patient sample positive for anti-MPO and anti-GBM: Besides a P-ANCA pattern on ethanol-fixed granulocytes and a granular C-ANCA pattern on formalin-fixed granulocytes, MPO-ANCA is characterized by a positive fluorescence signal on MPO but not on PR3 microdots. In addition a positive fluorescence signal on GBM microdots is shown.
In addition, the legend for Figure 1 was misleading. It has to be stated more clearly that the images are shown for illustrative purposes only. The correct Figure 1 and its legend appears below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: autoantibodies, renal autoimmune diseases, anti-PLA2R, anti-THSD7A, anti-nucleosomes, anti-dsDNA, ANCA, anti-PR3
Citation: Mastroianni-Kirsztajn G, Hornig N and Schlumberger W (2020) Corrigendum: Autoantibodies in renal diseases – clinical significance and recent developments in serological detection. Front. Immunol. 11:424. doi: 10.3389/fimmu.2020.00424
Received: 20 February 2020; Accepted: 24 February 2020;
Published: 11 March 2020.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2020 Mastroianni-Kirsztajn, Hornig and Schlumberger. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wolfgang Schlumberger, w.schlumberger@euroimmun.de